Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)- Insider Own56.99% Shs Outstand13.32M Perf Week-8.97%
Market Cap72.99M Forward P/E- EPS next Y0.00 Insider Trans0.00% Shs Float5.73M Perf Month1.11%
Income- PEG- EPS next Q-0.24 Inst Own2.08% Short Float0.92% Perf Quarter5.38%
Sales- P/S- EPS this Y35.88% Inst Trans-9.21% Short Ratio1.05 Perf Half Y126.45%
Book/sh- P/B- EPS next Y100.00% ROA- Short Interest0.05M Perf Year196.22%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.60 - 8.48 Perf YTD-23.46%
Dividend Est.- P/FCF- EPS past 5Y-9.64% ROI- 52W High-35.38% Beta0.42
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low242.33% ATR (14)0.51
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)39.90 Volatility5.43% 10.03%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q47.74% Payout- Rel Volume0.19 Prev Close5.55
Sales Surprise-15.25% EPS Surprise37.50% Sales Q/Q26.48% EarningsNov 14 BMO Avg Volume50.08K Price5.48
SMA20-13.36% SMA50-13.92% SMA20043.28% Trades Volume9,718 Change-1.26%
Date Action Analyst Rating Change Price Target Change
May-18-21Initiated BTIG Research Buy $4
Apr-26-21Initiated Mizuho Buy $3.80
Oct-23-20Initiated Oppenheimer Outperform $5
Sep-22-16Initiated Maxim Group Buy $4
Oct-29-15Resumed H.C. Wainwright Buy $2.50 → $3
Jun-23-15Initiated H.C. Wainwright Buy $2.50
Feb-16-24 07:00AM
Nov-14-23 07:00AM
Nov-08-23 07:00AM
Aug-11-23 07:00AM
Aug-01-23 07:00AM
08:00AM Loading…
Jul-20-23 08:00AM
May-28-23 08:35AM
May-17-23 07:35AM
Apr-26-23 09:35AM
Apr-17-23 07:11AM
Mar-21-23 04:30PM
Feb-06-23 08:07AM
Jan-06-23 08:42AM
07:00AM Loading…
Dec-15-22 07:00AM
Nov-17-22 05:39AM
Nov-14-22 08:15AM
Sep-23-22 07:00AM
Sep-07-22 07:00AM
Aug-12-22 08:35AM
Aug-05-22 08:38AM
Jul-08-22 07:00AM
Jun-02-22 06:34AM
May-26-22 04:30PM
May-25-22 07:53AM
May-24-22 07:00AM
08:15AM Loading…
May-12-22 08:15AM
May-10-22 09:25AM
May-02-22 10:15AM
Apr-01-22 07:27AM
Mar-31-22 07:15PM
Mar-28-22 07:00AM
Mar-23-22 07:00AM
Mar-04-22 07:00AM
Feb-23-22 04:36AM
Feb-16-22 07:00AM
Feb-15-22 05:03PM
Jan-20-22 08:50AM
Jan-18-22 07:00AM
Jan-09-22 07:28AM
Jan-03-22 07:00AM
Dec-17-21 07:00AM
Dec-10-21 07:15AM
Nov-25-21 04:34AM
Nov-22-21 07:17AM
Nov-15-21 07:00AM
Nov-12-21 07:00AM
Nov-05-21 07:00AM
Nov-02-21 07:00AM
Nov-01-21 03:01PM
Oct-25-21 07:50AM
Oct-06-21 07:17AM
Sep-27-21 02:01PM
Sep-20-21 07:00AM
Aug-23-21 09:58AM
Aug-14-21 03:10AM
Aug-12-21 10:05AM
Aug-10-21 07:00AM
Aug-02-21 03:01PM
Jul-25-21 03:49AM
Jun-10-21 07:00AM
May-27-21 07:00AM
May-17-21 10:20AM
May-13-21 07:00AM
May-11-21 07:00AM
Apr-28-21 10:39AM
Apr-26-21 02:11AM
Mar-30-21 07:00AM
Mar-24-21 03:57PM
Mar-23-21 04:01PM
Mar-11-21 04:30PM
Mar-08-21 10:17AM
Feb-25-21 12:08AM
Feb-16-21 07:00AM
Jan-28-21 07:00AM
Jan-21-21 07:00AM
Jan-11-21 12:17AM
Jan-08-21 07:00AM
Dec-23-20 07:00AM
Dec-16-20 07:00AM
Dec-12-20 02:20PM
Nov-30-20 09:05AM
Nov-26-20 11:16PM
CASI Pharmaceuticals, Inc. engages in developing and commercializing therapeutics and pharmaceutical products. The company was founded in 1991 and is headquartered in Beijing, China.